Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 12837 results
Sort by: relevance publication year

Review article: evolving concepts in treatment and disease modification in ulcerative colitis

JOURNAL ARTICLE published March 2008 in Alimentary Pharmacology & Therapeutics

Authors: S. B. HANAUER

Systematic review: non‐invasive prognostic tests for primary sclerosing cholangitis

JOURNAL ARTICLE published April 2021 in Alimentary Pharmacology & Therapeutics

Authors: Areej Mazhar | Mark W. Russo

Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole

JOURNAL ARTICLE published 2 October 2001 in Alimentary Pharmacology & Therapeutics

Authors: T. Andersson | K. RÖhss | E. Bredberg | M. Hassan‐Alin

Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study

JOURNAL ARTICLE published October 2018 in Alimentary Pharmacology & Therapeutics

Authors: Giuseppina Novo | Francesca Macaione | Lydia Giannitrapani | Maria Giovanna Minissale | Vito Bonomo | Francesco Indovina | Salvatore Petta | Maurizio Soresi | Giuseppe Montalto | Salvatore Novo | Antonio Craxi | Anna Licata

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

JOURNAL ARTICLE published October 2015 in Alimentary Pharmacology & Therapeutics

Authors: S. Zeuzem | R. Flisiak | J. M. Vierling | W. Mazur | G. Mazzella | S. Thongsawat | D. Abdurakhmanov | N. Van Kính | P. Calistru | J. Heo | C. Stanciu | M. Gould | M. Makara | S.‐J. Hsu | P. Buggisch | D. Samuel | D. Mutimer | B. Nault | M. Merz | W. Bao | L. H. Griffel | C. Brass | N. V. Naoumov | the ESSENTIAL II Study Group

Real‐world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease

JOURNAL ARTICLE published May 2014 in Alimentary Pharmacology & Therapeutics

Authors: D. T. Rubin | R. Mody | K. L. Davis | C.‐C. Wang

Editorial: when and how to use steatosis biomarkers?

JOURNAL ARTICLE published December 2014 in Alimentary Pharmacology & Therapeutics

Authors: V. W.‐S. Wong | G. L.‐H. Wong

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014

JOURNAL ARTICLE published April 2018 in Alimentary Pharmacology & Therapeutics

Research funded by National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007760)

Authors: S. Ballou | W. Hirsch | P. Singh | V. Rangan | J. Nee | J. Iturrino | T. Sommers | J. Zubiago | N. Sengupta | A. Bollom | M. Jones | A. C. Moss | S. N. Flier | A. S. Cheifetz | A. Lembo

TNFα processing enzyme inhibitors prevent aspirin‐induced TNFα release and protect against gastric mucosal injury in rats

JOURNAL ARTICLE published November 1998 in Alimentary Pharmacology & Therapeutics

Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration

JOURNAL ARTICLE published August 1994 in Alimentary Pharmacology & Therapeutics

Authors: C. BRICNOLA | G. DE SIMONE | C. BELLOLI | P. IANNONE | A. BELLUZZI | P. GIONCHETTI | M. CAMPIERI | L. BARBARA

Omepmazole or high‐dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’of H2‐receptor antagonists

JOURNAL ARTICLE published April 1990 in Alimentary Pharmacology & Therapeutics

Authors: L. LUNDELL | L. BACKMAN | P. EKSTRÖM | L.‐H. ENANDER | O. FAUSA | T. LIND | H. LÖNROTH | S. SANDMARK | B. SANDZÉN | P. UNGE | I. H. WESTIN

Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion

JOURNAL ARTICLE published April 1992 in Alimentary Pharmacology & Therapeutics

Authors: G. O. YOUNG | N. STEMMET | A. LASTOVICA | E. L. VAN DER MERWE | J. A. LOUW | I. M. MODLIN | I. N. MARKS

The interaction between Helicobacter pylori culture filtrate and indomethacin: effects on the integrity of human gastric antral mucosa and its prostaglandin E2 production in vitro

JOURNAL ARTICLE published June 1990 in Alimentary Pharmacology & Therapeutics

Authors: A. S. TAHA | R. W. KELLY | C. G. GEMMELL | F. D. LEE | R. I. RUSSELL

Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis

JOURNAL ARTICLE published November 2023 in Alimentary Pharmacology & Therapeutics

Authors: Thierry Poynard | Olivier Deckmyn | Valentina Peta | Valérie Paradis | Jean‐Francois Gautier | Angélique Brzustowski | Pierre Bedossa | Laurent Castera | Stanislas Pol | Dominique Valla | the Quid‐Nash Consortium

Review article: the treatment of hepatitis C virus recurrence after liver transplantation

JOURNAL ARTICLE published July 2007 in Alimentary Pharmacology & Therapeutics

Authors: R. R. ARJAL | J. R. BURTON JR | F. VILLAMIL | H. R. ROSEN

Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile

JOURNAL ARTICLE published April 2003 in Alimentary Pharmacology & Therapeutics

Authors: S. P. Pereira | I. M. Bain | D. Kumar | R. H. Dowling

Impact of thiopurine discontinuation at anti‐tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study

JOURNAL ARTICLE published May 2022 in Alimentary Pharmacology & Therapeutics

Research funded by Danmarks Grundforskningsfond (DNRF148) | Foundation for the National Institutes of Health (1K23DK111995‐01A1)

Authors: Sandra Bohn Thomsen | Ryan C. Ungaro | Kristine H. Allin | Rahma Elmahdi | Gry Poulsen | Mikael Andersson | Jean‐Frederic Colombel | Tine Jess

Naloxone treatment for irritable bowel syndrome — a randomized controlled trial with an oral formulation

JOURNAL ARTICLE published September 2002 in Alimentary Pharmacology & Therapeutics

Authors: N. D. Hawkes | J. Rhodes | B. K. Evans | P. Rhodes | A. B. Hawthorne | G. A. O. Thomas

Genetic risk factors forClostridium difficileinfection in ulcerative colitis

JOURNAL ARTICLE published September 2013 in Alimentary Pharmacology & Therapeutics

Research funded by National Institutes of Health (K23 DK097142,U01 DK062432,R01 DK064869)

Authors: A. N. Ananthakrishnan | E. C. Oxford | D. D. Nguyen | J. Sauk | V. Yajnik | R. J. Xavier

Persisting symptoms and decreased health‐related quality‐of‐life in a cross‐sectional study of treated achalasia patients

JOURNAL ARTICLE published September 2007 in Alimentary Pharmacology & Therapeutics

Authors: R. FRANKHUISEN | M. A. VAN HERWAARDEN | R. HEIJKOOP | A. J. P. M. SMOUT | A. BARON | J. R. VERMEIJDEN | H. G. GOOSZEN | M. SAMSOM